ProQR Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $4,644 | $2,915 | $3,817 | $4,519 |
Gross Profit | 3,971 | 2,915 | 3,817 | 4,519 |
EBITDA | -8,366 | -10,335 | -11,574 | -10,138 |
EBIT | -9,039 | -11,006 | -12,249 | -10,816 |
Net Income | -8,836 | -11,006 | -12,179 | -10,079 |
Net Change In Cash | 4,644 | 2,915 | 3,817 | 4,519 |
Free Cash Flow | -13,593 | -12,404 | -11,502 | -16,022 |
Cash | 92,373 | 106,883 | 119,765 | 143,033 |
Basic Shares | 103,011 | 110,060 | 105,343 | 105,296 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $15,278 | $18,905 | $6,514 | $3,594 |
Gross Profit | 12,681 | 18,905 | 6,514 | 3,594 |
EBITDA | -39,558 | -24,122 | -24,097 | -56,460 |
EBIT | -42,154 | -26,883 | -26,610 | -58,981 |
Net Income | -40,519 | -27,763 | -28,119 | -64,424 |
Net Change In Cash | 15,278 | 18,905 | 6,514 | 3,594 |
Free Cash Flow | -51,687 | -37,811 | 20,177 | -69,216 |
Cash | 92,373 | 149,408 | 131,370 | 94,775 |
Basic Shares | 105,334 | 81,665 | 81,011 | 71,641 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$0.09 |
2025-09-30 | -$0.10 |
2025-06-30 | -$0.12 |
2025-03-31 | -$0.11 |
